Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

Time Course of Apoptotic Tumor Response After a Single Dose of Chemotherapy: Comparison with 99mTc-Annexin V Uptake and Histologic Findings in an Experimental Model

Toshiki Takei, Yuji Kuge, Songji Zhao, Masayuki Sato, H. William Strauss, Francis G. Blankenberg, Jonathan F. Tait and Nagara Tamaki
Journal of Nuclear Medicine December 2004, 45 (12) 2083-2087;
Toshiki Takei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Kuge
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Songji Zhao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masayuki Sato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. William Strauss
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francis G. Blankenberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan F. Tait
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nagara Tamaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Radioactivity and rates of positively stained cells. *P < 0.05 compared with control group.

Tables

  • Figures
    • View popup
    TABLE 1

    Biodistribution of 99mTc-Annexin V

    BiodistributionTime after cyclophosphamide treatment (h) (n = 5)P (K–W)
    0 (control)41220
    Blood0.039 ± 0.0060.041 ± 0.0050.041 ± 0.0070.037 ± 0.001NS
    Tumor0.050 ± 0.0100.048 ± 0.0080.052 ± 0.0140.077 ± 0.007*<0.001
    Muscle0.008 ± 0.0010.011 ± 0.0080.009 ± 0.0020.010 ± 0.000NS
    Thymus0.031 ± 0.0040.041 ± 0.0070.065 ± 0.012*0.068 ± 0.011*<0.001
    Spleen1.321 ± 0.1832.111 ± 0.432*2.410 ± 0.463*2.355 ± 0.157*0.001
    BM0.621 ± 0.0481.237 ± 0.193*1.493 ± 0.429*2.048 ± 0.521*<0.001
    Liver0.586 ± 0.0420.740 ± 0.1110.743 ± 0.2040.669 ± 0.087NS
    Kidney8.317 ± 0.2956.897 ± 0.9685.958 ± 1.452*5.945 ± 0.583*0.002
    TBR1.306 ± 0.2171.197 ± 0.2881.281 ± 0.3122.052 ± 0.164*<0.001
    TMR5.908 ± 0.8395.873 ± 2.6925.733 ± 1.6907.528 ± 0.586*<0.001
    • ↵* P < 0.05 compared with control groups.

    • K-W = Kruskal-Wallis test; NS = not significant; BM = bone marrow; TBR = tumor-to-blood ratio; TMR = tumor-to-muscle ratio.

    • Data are (%ID/g) × kg (mean ± SD) except TBR and TMR.

    • View popup
    TABLE 2

    Weight of Organs

    HeightTime after cyclophosphamide treatment (h) (n = 5)P (K–W)
    0 (control)41220
    Whole body252.4 ± 21.34247.2 ± 17.73251.4 ± 15.21248.6 ± 13.52NS
    Tumor0.964 ± 0.1810.940 ± 0.2651.031 ± 0.1470.952 ± 0.130NS
    Muscle1.041 ± 0.5411.036 ± 0.2951.264 ± 0.2881.169 ± 0.102NS
    Thymus0.522 ± 0.0660.454 ± 0.1390.411 ± 0.0580.312 ± 0.066<0.01
    Spleen0.723 ± 0.0950.549 ± 0.0940.433 ± 0.0610.392 ± 0.034<0.01
    Liver3.343 ± 0.4793.395 ± 0.3943.956 ± 0.8283.446 ± 0.371NS
    Kidney1.713 ± 0.1411.755 ± 0.1641.810 ± 0.1381.838 ± 0.056NS
    • K-W = Kruskal-Wallis test; NS = not significant.

    • Data are in grams (mean ± SD).

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 45 (12)
Journal of Nuclear Medicine
Vol. 45, Issue 12
December 1, 2004
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Time Course of Apoptotic Tumor Response After a Single Dose of Chemotherapy: Comparison with 99mTc-Annexin V Uptake and Histologic Findings in an Experimental Model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Time Course of Apoptotic Tumor Response After a Single Dose of Chemotherapy: Comparison with 99mTc-Annexin V Uptake and Histologic Findings in an Experimental Model
Toshiki Takei, Yuji Kuge, Songji Zhao, Masayuki Sato, H. William Strauss, Francis G. Blankenberg, Jonathan F. Tait, Nagara Tamaki
Journal of Nuclear Medicine Dec 2004, 45 (12) 2083-2087;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Time Course of Apoptotic Tumor Response After a Single Dose of Chemotherapy: Comparison with 99mTc-Annexin V Uptake and Histologic Findings in an Experimental Model
Toshiki Takei, Yuji Kuge, Songji Zhao, Masayuki Sato, H. William Strauss, Francis G. Blankenberg, Jonathan F. Tait, Nagara Tamaki
Journal of Nuclear Medicine Dec 2004, 45 (12) 2083-2087;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • Looking Through the Vascular Normalization Window: Timing Antiangiogenic Treatment and Chemotherapy with 99mTc-Annexin A5
  • Time Course of Paclitaxel-Induced Apoptosis in an Experimental Model of Virus-Induced Breast Cancer
  • Sequential 99mTc-Hydrazinonicotinamide-Annexin V Imaging for Predicting Response to Chemotherapy
  • A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties
  • Enhanced Apoptotic Reaction Correlates with Suppressed Tumor Glucose Utilization After Cytotoxic Chemotherapy: Use of 99mTc-Annexin V, 18F-FDG, and Histologic Evaluation
  • Google Scholar

More in this TOC Section

  • Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
  • Tumor-Specific Binding of Radiolabeled PEGylated GIRLRG Peptide: A Novel Agent for Targeting Cancers
  • PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire